BridgeMD
New treatment option for Parkinson Disease
Official title Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
ClinicalTrials.gov ID: NCT06540989
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether noise-augmented feedback using automatic speech recognition improves intelligibility and social participation in individuals with Parkinson's disease. The main questions the investigators will address are: Does noise-augmented feedback lead to increased intelligibility, as measured by transcription accuracy scores?
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Participants will qualify for the study if:
- They are 50-80 years old,
- They have a medical diagnosis of PD,
- They are within stages I-IV of Hoehn \& Yahr Scale,
- Their antiparkinsonian medication schedule is stable,
You likely can't join if
- Participants will be excluded from the study if they:
- Present with atypical parkinsonism at the time of screening (or other neurological condition),
- Underwent neurosurgery treatment (DBS),
- Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
- Present with any speech or voice pathology that is unrelated to PD.
See the full eligibility criteria
- Participants will qualify for the study if:
- They are 50-80 years old,
- They have a medical diagnosis of PD,
- They are within stages I-IV of Hoehn \& Yahr Scale,
- Their antiparkinsonian medication schedule is stable,
- They present with mild to moderate dysarthria,
- They score ≥ 25 in the MMSE,
- They score ≤ 24 in the BDI-III.
- Participants will be excluded from the study if they:
- Present with atypical parkinsonism at the time of screening (or other neurological condition),
- Underwent neurosurgery treatment (DBS),
- Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
- Present with any speech or voice pathology that is unrelated to PD.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.